Cargando…
The pharmacogenetics of the new-generation antipsychotics – A scoping review focused on patients with severe psychiatric disorders
Exploring the possible correlations between gene variations and the clinical effects of the new-generation antipsychotics is considered essential in the framework of personalized medicine. It is expected that pharmacogenetic data will be useful for increasing the treatment efficacy, tolerability, th...
Autor principal: | Vasiliu, Octavian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978195/ https://www.ncbi.nlm.nih.gov/pubmed/36873203 http://dx.doi.org/10.3389/fpsyt.2023.1124796 |
Ejemplares similares
-
Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?
por: Vasiliu, Octavian
Publicado: (2022) -
The current state of research for psychobiotics use in the management of psychiatric disorders–A systematic literature review
por: Vasiliu, Octavian
Publicado: (2023) -
Impact of SGLT2 inhibitors on metabolic status in patients with psychiatric disorders undergoing treatment with second‑generation antipsychotics (Review)
por: Vasiliu, Octavian
Publicado: (2023) -
Therapeutic management of buying/shopping disorder: A systematic literature review and evidence-based recommendations
por: Vasiliu, Octavian
Publicado: (2022) -
Current Status of Evidence for a New Diagnosis: Food Addiction-A Literature Review
por: Vasiliu, Octavian
Publicado: (2022)